ClinicalTrialsFinder
RecruitingNCT04467333

Giessen Pulmonary Hypertension in Lung Cancer Registry

Sponsor

University of Giessen

Enrollment

500 participants

Start Date

Jun 29, 2020

Study Type

OBSERVATIONAL

Conditions

Pulmonary Hypertension Due to Lung Diseases and Hypoxia

Summary

The aim of this study is to investigate the frequency and implications of pulmonary hypertension in lung cancer patients. To do so, data will be collected from all lung cancer patients at the university hospital Giessen. All data will be analyzed for possible hints of pulmonary hypertension as a comorbidity in lung cancer patients. All information will be generated from the regular guidelines based course of treatment and there will be no interventions. This study will serve as a prospective register for all lung cancer patients treated at the university hospital Giessen.

Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Patient with lung cancer at the University of Giessen lung Cancer Center.

Exclusion Criteria1

  • \-

Interventions

OTHERAll lung cancer patients.

There will be no specific interventions. All patients will receive guidelines based therapy of lung cancer and their comorbidities.

Locations(1)

University hospital Giessen

Giessen, Hesse, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04467333

Related Trials

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

NCT0638842159 locations

Ventilator Pressure and Optimization of Compliance and Hemodynamics

NCT065129351 location

Pulmonary Hypertension Biorepository and Registry

NCT048085961 location